skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines agalsidase betaQuestion & answer

agalsidase beta · Medicine question

How is agalsidase beta expected to be metabolised?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Agalsidase beta is a protein expected to be metabolically degraded through peptide hydrolysis.

Sources for this answer

Fabrazyme 35mg powder for concentrate for solution for infusionSANOFI · emc · SmPC §5.2 Pharmacokinetic properties · Version 2Document updated 20 January 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

agalsidase beta

More questions about agalsidase beta

Can agalsidase beta (Fabrazyme) affect driving or using machines on the day of infusion?Have studies assessed the effects of agalsidase beta (Fabrazyme) on fertility?Have the safety and efficacy of agalsidase beta (Fabrazyme) been established in patients older than 65 years?How does agalsidase beta work as enzyme replacement therapy in Fabry disease?How much sodium does each vial of agalsidase beta (Fabrazyme) contain?Is agalsidase beta likely to cause cytochrome P450-mediated drug interactions?

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the agalsidase beta guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX